Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Current status and future development

被引：10
|
作者：
Karakontaki, Foteini, V [1 ]
Panselinas, Efstratios S. [2 ]
Polychronopoulos, Vlasios S. [1 ]
Tzioufas, Athanasios G. [3 ]
机构：
[1] Hygeia Hosp, Dept Pulm Med, Athens, Greece
[2] Pulmonologist, Tripoli, Greece
[3] Univ Athens, Sch Med, Dept Pathophysiol, 75 M Asias St,Bldg 16,Room 32, Athens 11527, Greece
来源：
AUTOIMMUNITY REVIEWS | 2021年 / 20卷 / 02期
关键词：
Autoimmune rheumatic diseases; Interstitial lung disease; Rheumatoid arthritis; Sjogren's syndrome; Vasculitis; Myositis; Scleroderma immunosuppressive drugs; Targeted treatment; Anti-fibrotic treatment; CONNECTIVE-TISSUE DISEASE; ANTI-SYNTHETASE SYNDROME; PRIMARY SJOGRENS-SYNDROME; MYCOPHENOLATE-MOFETIL; OPEN-LABEL; RITUXIMAB THERAPY; IMATINIB MESYLATE; ARTHRITIS; SCLEROSIS; EFFICACY;
D O I：
10.1016/j.autrev.2020.102742
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Autoimmune rheumatic diseases (ARD) are characterized by systemic manifestations and multiple organ involvement, including the lung. Interstitial Lung Disease (ILD) is a cardinal manifestation of lung involvement in patients with ARD and is associated with significant morbidity and mortality. Corticosteroids and immunosuppressive drugs are used as first -line treatment. Targeted therapies, such as biological disease modifying anti-rheumatic drugs (DMARDS) and anti- fibrotic agents are new treatment options. In this review we discuss the role of targeted therapies in patients with ILD secondary to ARD.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis
    Chan, Edward K. L.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 63 (02) : 178 - 193
  • [22] Determinants for worsening in systemic autoimmune rheumatic disease-associated interstitial lung disease: a systematic review and meta-analysis of cohort studies
    Yao, Jiaheng
    Wang, Jun
    Guo, Luhan
    Su, Peipei
    Li, Jiansheng
    Li, Bin
    FRONTIERS IN MEDICINE, 2024, 11
  • [23] Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review
    Campochiaro, Corrado
    Lazzaroni, Maria Grazia
    Bruni, Cosimo
    Zanatta, Elisabetta
    De Luca, Giacomo
    Matucci-Cerinic, Marco
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [24] Immunoglobulin replacement for secondary immunodeficiency after B-cell targeted therapies in autoimmune rheumatic disease: Systematic literature review
    Wijetilleka, Sonali
    Mukhtyar, Chetan
    Jayne, David
    Ala, Aftab
    Bright, Philip
    Chinoy, Hector
    Harper, Lorraine
    Kazmi, Majid
    Kiani-Alikhan, Sorena
    Li, Charles
    Misbah, Siraj
    Oni, Louise
    Price-Kuehne, Fiona
    Salama, Alan
    Workman, Sarita
    Wrench, David
    Karim, Mohammed Yousuf
    AUTOIMMUNITY REVIEWS, 2019, 18 (05) : 535 - 541
  • [25] Advancing autoimmune Rheumatic disease treatment: CAR-T Cell Therapies - Evidence, Safety, and future directions
    Ohno, Ryunosuke
    Nakamura, Akihiro
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 67
  • [26] A systematic review of the incidence, risk factors and prognosis of acute exacerbation of systemic autoimmune disease-associated interstitial lung disease
    Kamiya, Hiroyuki
    Panlaqui, Ogee Mer
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [27] The role of antifibrotic therapies in the treatment of systemic sclerosis-associated interstitial lung disease
    Boleto, Goncalo
    Avouac, Jerome
    Allanore, Yannick
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
  • [28] Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review
    de Souza, F. H. C.
    de Araujo, D. B.
    Hoff, L. S.
    Baldi, B. G.
    Faria, M. S. M. S.
    da Rocha Junior, L. F.
    Da Silva, L. R. S.
    Pinto, Behrens
    Bezerra, M. C.
    Miossi, R.
    Cordeiro, R. A.
    Shinjo, S. K.
    REUMATISMO, 2023, 75 (01) : 1 - 14
  • [29] Systemic Sclerosis With Associated Interstitial Lung Disease: Management Considerations and Future Directions
    Bernstein, Elana J.
    Huggins, J. Terrill
    Hummers, Laura K.
    Owens, Gary M.
    AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (07): : S138 - S146
  • [30] Systemic sclerosis associated interstitial lung disease: a survey of current practices in France
    Nicolas, Amelie
    Leroy, Sylvie
    Mouthon, Luc
    Uzunhan, Yurdagul
    Cottin, Vincent
    Mekinian, Arsene
    Queyrel, Viviane
    Hachulla, Eric
    Gachet, Benoit
    Launay, David
    Martis, Nihal
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
12345